DCF ScreenerData as of Oct 10, 2026, 1:06 AM UTC
← Screener

ZBH Zimmer Biomet Holdings, Inc.

Healthcare

Price
$89.68
Intrinsic value
$37.00
Buy price
$29.60
Discount
-142.4%
Overvalued

Live signals (1)

Daily bars as of Oct 8, 2026
  • FS-BullishFailure Swing (bullish)Bullish ↑

    Price undercut a recent swing low and closed back above it - the breakdown failed and trapped the sellers who chased it.

    Fired Oct 8, 2026on the latest daily bar37.4% win rate · 1.07x profit factor

A pattern is reported for 5 bars after it fires (the sweet-spot fill window), so an older bar count means the entry has had longer to play out - not that the signal is stronger. Win rate and profit factor are the pattern's backtested averages across the S&P 500, not a forecast for this ticker.

DCF walkthrough

Near-term growth (g1)5.85%
Terminal growth (g2)3.50%
Years of g1 growth4
Discount rate9.00%
Margin of safety20.00%
Operating CF
$1,743,300,000.00
Total debt
$7,601,699,840.00
Cash & STI
$464,500,000.00
Shares out.
192,800,000
Overvalued
Intrinsic value$36.98
Buy price (with MOS)$29.59
Current price$89.68
Discount to intrinsic value-142.5%

7-step quality scorecard

ROE quality
LOW
Average ROE
5.7%
Current ROE
5.6%
Minimum ROE
1.9%
Debt quality
MODERATE
Debt / Equity
0.60x
Moat proxy
MODERATE_PROXY
Cash-flow reliability
OK
Operating CF / Net income
2.16x

Technical chart

Confluence: DOWNTREND (1/3)

Weekly candles, ~3 years. Yellow line: 10-week EMA. Dashed lines: Fibonacci retracement of the last 52-week swing. Green arrow: an active DR1 support reclaim (see Live signals above for when it fired).

Assumptions & data quality

Data source
yfinance
Growth (g1) source
min(revenueCAGR,cfCAGR)
Valuation model
DCF_OCF
Debt as % of DCF PV
53.2%
Public economic interest
99.9%

These are model outputs built on assumptions (growth rate, discount rate, margin of safety), not facts - trust but verify, especially for LOW cash-flow-reliability or UNKNOWN-quality rows.